External Assessment Centres

Description

The National Institute for Health and Care Excellence (NICE) seeks to commission external assessment group (EAG) services to support a variety of technology evaluation programmes from 01/04/2022 for a period of three years in the first instance. More information on NICE's programmes can be found at: http://www.nice.org.uk/. More information on the NICE strategy can be found here. NICE's technology evaluation programmes require a range of high-quality Health Technology Assessment (HTA) services from organisations with knowledge of novel technologies, the life sciences industry and HTA methods development. NICE uses its technology programmes to develop guidance on the value of new and novel medicines, devices, diagnostic and digital (including those with Artificial Intelligence) technologies that have the potential to offer substantial benefit to patients and/or the NHS, and on the safety and efficacy of interventional procedures. NICE also facilitates specialist clinical data collection and analysis services (and increasingly does this in close collaboration with manufacturers, NHS England and NHS Improvement and national registries) to support guidance producing programmes. NICE provides national guidance and advice to improve health and social care. NICE does this by: • Producing evidence-based guidance and advice for health, public health and social care practitioners. • Developing quality standards and performance metrics for those providing and commissioning health, public health and social care services. • Providing a range of information services for commissioners, practitioners and managers across the spectrum of health and social care. NICE's guidance and advice can be used by the NHS, local authorities, employers, voluntary groups and anyone else involved in delivering care or promoting wellbeing. Documents describing the methods and processes employed by NICE in developing its guidance are available from NICE's website (www.nice.org.uk). Lot 1: Clinical and economic evidence assessment Including: critical appraisal of company submissions; evidence synthesis; economic modelling; support for guidance review processes; preparation of evidence summaries; support for guidance on the full range of diagnostic technologies and pathways, confirmation of regulatory status, preparation of manuscripts for publication in peer reviewed journals. Additional information: Please note that the Lot names and details of scope are subject to change pending further development of the contract. Full and final details of the Lots and description of scope will be confirmed in the contract notice when released. Please refer to Section VI for details of the Supplier information day Lot 2: Primary data collection, analysis and oversight Including: pragmatic facilitation of collaborative research; real-world evidence collection activities including data collection feasibility assessments, establishing patient registries, analysing observational/registry data and similar schemes, oversight of data collections, and preparation of manuscripts for publication in peer reviewed journals, research and ethics advice service (may include a range of services from applying for regulatory approval to conduct research re. ethics, HRA and R&D processes or just advice on the regulatory requirements of proposed data collection). Additional information: Please note that the Lot names and details of scope are subject to change pending further development of the contract. Full and final details of the Lots and description of scope will be confirmed in the contract notice when released. Please refer to Section VI for details of the Supplier information day Lot 3: Decision and methodological support services Including: providing decision support to individual topics; advanced methodological development for all NICE health technology programmes, providing technical resource support to guidance topics, providing educational training and support to NICE staff and committees, preparation of manuscripts for publication in peer reviewed journals. Additional information: Please note that the Lot names and details of scope are subject to change pending further development of the contract. Full and final details of the Lots and description of scope will be confirmed in the contract notice when released. Please refer to Section VI for details of the Supplier information day